Clinical Trial Record

Return to Clinical Trials

Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study


2011-10


2012-10


2012-10


140

Study Overview

Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.

N/A

  • Adenocarcinoma of Head of Pancreas
    • ZMS-001

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2011-10-18  

    N/A  

    2011-10-19  

    2011-10-19  

    N/A  

    2011-10-20  

    2011-10-20  

    N/A  

    2011-10  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Mengsu Zeng, MD, PhD

    Phone Number: +86-021-64041990-2130

    Email: zengmengsu@gmail.com

    Study Contact Backup

    Name: Xiuzhong Yao, MD, PhD

    Phone Number: +86-021-64041990-5425

    Email: fjqzyaoxz02@163.com

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:

    Accepts Healthy Volunteers:

      Inclusion Criteria:

    • Patients with (or suspected) pancreatic head cancer
    • Being examined by contrasted-enhanced MDCT
    • Receiving surgical treatment (including palliative surgery) in all research centers

    • Exclusion Criteria:

    • Patients having (or suspected) pregnancy or breast-feeding
    • Patients having allergic reactions to iodinated contrast agents or Hypersensitivity reactions to allergens(including drugs)
    • Patients receiving ERCP before contrasted-enhanced MDCT examination
    • Patients without surgery because of a high degree of surgical risk

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.

    • Changhai Hospital
    • Shanghai Cancer Hospital, China
    • Ruijin Hospital
    • Huashan Hospital
    • Huadong Hospital

    • STUDY_CHAIR: Mengsu Zeng, MD, PhD, Radiology Department, Zhongshan Hospital of Fudan University

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available